Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Nexgel Logo
Nexgel Growth Score
90
CB Rank
15625
Heat Score
66
NEXGEL is a biotechnology company that engages in a trans-dermal delivery system.
Founded
obfuscation
PublicPost-IPO Debt Langhorne, Pennsylvania, United States11-50 nexgel.com/
Biotechnology
Cosmetics
Health Care
Hospital
Manufacturing
Overview

Nexgel
Total Funding
obfuscation
Growth Score
90
Heat Score
66

Total Funding
obfuscation
obfuscation
Post-IPO Debt raised
obfuscation
Growth Score90
-3 pts
in past quarter
Heat Score 66
-10 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Nexgel

CB Rank
15625
NEXGEL is a biotechnology company that engages in a trans-dermal delivery system.
Founded
obfuscation
PublicPost-IPO Debt Langhorne, Pennsylvania, United States11-50 nexgel.com/
Biotechnology
Cosmetics
Health Care
Hospital
Manufacturing

Funding Rounds

Post-IPO Debt
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation
Post-IPO Debt
OBF
in
obfuscation

Key People

Details

Legal Name NexGel, Inc.
Operating Status Active
Stock Symbol  NASDAQ:NXGL
Company Type For Profit
About the Company
NEXGEL Advanced Hydrogel Solutions is a manufacturer of a unique trans-dermal delivery system and is a skin friendly patch company. It specializes in the fields of biotechnology, cosmetics, healthcare, hospital, and manufacturing. It was founded in Langhorne, Pennsylvania.
Phone Number (215)-702-8550
Contact Email info@nexgel.com
Predictions & Insights

Growth Insight

See this Growth Insight
Nexgel is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Products & Services

Arctic5 Hydrogel
A hydrogel patch with 94.5% water content designed for hydration and soothing of skin, suitable for burns, blisters, callouses, scars, first aid, and wound care.
Arctic10 Hydrogel
A hydrogel patch with 90% water content and moderate adhesion, used as a transdermal delivery system for facemasks, under-eye treatments, pain relief, first aid, and wound care.

Research & Development

Nexgel is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 8
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Debt - Nexgel Logo
Post-IPO Debt - Nexgel
1
obfuscation
Sequence LifeSciencePost-IPO Debt
obfuscation
Post-IPO Debt - Nexgel Logo
Post-IPO Debt - Nexgel
1
obfuscation
Sequence LifeSciencePost-IPO Debt
obfuscation
Post-IPO Debt - Nexgel Logo
Post-IPO Debt - Nexgel
1
obfuscation
Sequence LifeSciencePost-IPO Debt
obfuscation
Post-IPO Debt - Nexgel Logo
Post-IPO Debt - Nexgel
1
obfuscation
Sequence LifeSciencePost-IPO Debt
obfuscation
Post-IPO Debt - Nexgel Logo
Post-IPO Debt - Nexgel
1
obfuscation
Sequence LifeSciencePost-IPO Debt

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 8
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Debt - Nexgel Logo
Post-IPO Debt - Nexgel
1
obfuscation
Sequence LifeSciencePost-IPO Debt
obfuscation
Post-IPO Debt - Nexgel Logo
Post-IPO Debt - Nexgel
1
obfuscation
Sequence LifeSciencePost-IPO Debt
obfuscation
Post-IPO Debt - Nexgel Logo
Post-IPO Debt - Nexgel
1
obfuscation
Sequence LifeSciencePost-IPO Debt
obfuscation
Post-IPO Debt - Nexgel Logo
Post-IPO Debt - Nexgel
1
obfuscation
Sequence LifeSciencePost-IPO Debt
obfuscation
Post-IPO Debt - Nexgel Logo
Post-IPO Debt - Nexgel
1
obfuscation
Sequence LifeSciencePost-IPO Debt

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Sequence LifeScience Logo
Sequence LifeScience
Yes
Post-IPO Debt - Nexgel Logo
Post-IPO Debt - Nexgel
—
Sequence LifeScience Logo
Sequence LifeScience
Yes
Post-IPO Debt - Nexgel Logo
Post-IPO Debt - Nexgel
—
Sequence LifeScience Logo
Sequence LifeScience
Yes
Post-IPO Debt - Nexgel Logo
Post-IPO Debt - Nexgel
—
Sequence LifeScience Logo
Sequence LifeScience
Yes
Post-IPO Debt - Nexgel Logo
Post-IPO Debt - Nexgel
—
Sequence LifeScience Logo
Sequence LifeScience
Yes
Post-IPO Debt - Nexgel Logo
Post-IPO Debt - Nexgel
—

Investments

Number of Acquisitions 3

Investment Breakdown

Number of Acquisitions 3
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 2 Board Members and Advisors 3 Contacts 3

Employee Profiles

Board Members and Advisors

News

News and Press

News•Jun 4, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 19, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 6, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 27, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

1,219
625.6%
 in past month

Interest Signals

TopicSurge Score
Washington Post Logo
Washington Post
70
Google (GOOG) Logo
Google (GOOG)
69

Actively Used Products

11Nexgel uses 11 technology products and services including HTML5, Google Tag Manager, and  Google Fonts, according to G2 Stack.

Active Website Tech Count

32Nexgel is actively using 32 technologies for its website, according to BuiltWith. These include Apple Mobile Web Clips Icon, LetsEncrypt, and  DMARC.

Total IP

12Nexgel has 1 registered patent in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery. Additionally, Nexgel has registered 11 trademarks with the most popular class being 'Bleaching, cleaning, polishing, scouring and abrasive preparations; cosmetics', according to IPqwery.
Sub-Organizations

Sub-Organizations

Number of Sub-Orgs 1
Which industries do these Sub-Organization operate in?
NexGelRx, Logo
NexGelRx,Subsidiary
Frequently Asked Questions

Where is Nexgel's headquarters? Nexgel is located in Langhorne, Pennsylvania, United States.Who invested in Nexgel? Nexgel has 2 investors including Sequence LifeScience and  STADA Arzneimittel AG.When was the last funding round for Nexgel? Nexgel closed its last funding round on
obfuscation
from a Post-IPO Debt round.Who are Nexgel's competitors? Alternatives and possible competitors to Nexgel may include Palvella Therapeutics, Neurelis, and  N1 Life.How much funding has Nexgel raised to date? Nexgel has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(5d42803 1)
|